Addressing Immunosenescence: A Vital Concern for Elderly MS Patients
Vincent Van Pesch, a neurologist from Clinique Universitaire Saint-Luc in Belgium, discusses the importance of addressing immunosenescence in multiple sclerosis (MS) among elderly patients. As people with MS are living longer, the aging of the immune system can lead to increased susceptibility to infections, reduced vaccine response, and possibly higher autoreactive cell reactivity. This, coupled with disease-modifying treatments, may increase the risk of infections and cancer, particularly with high-efficacy therapies.
If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.